1 citations · 1 across the 5 of their papers we have counts for
24 papers
Blinded sample size re-calculation in multiple composite population designs with normal data and baseline adjustments
Roland Gerard Gera, Tim Friede
The increasing interest in subpopulation analysis has led to the development of various new trial designs and analysis methods in the fields of personalized medicine and targeted t…
Design aspects of COVID-19 treatment trials: Improving probability and time of favourable events
Jan Beyersmann, Tim Friede, Claudia Schmoor
As a reaction to the pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a multitude of clinical trials for the treatment of SARS-CoV-2 or the resulting c…
Is there a role for statistics in artificial intelligence?
Sarah Friedrich, Gerd Antes, Sigrid Behr +11
The research on and application of artificial intelligence (AI) has triggered a comprehensive scientific, economic, social and political discussion. Here we argue that statistics,…
Data monitoring committees for clinical trials evaluating treatments of COVID-19
Tobias Mütze, Tim Friede
The first cases of coronavirus disease 2019 (COVID-19) were reported in December 2019 and the outbreak of SARS-CoV-2 was declared a pandemic in March 2020 by the World Health Organ…
Causal inference methods for small non-randomized studies: Methods and an application in COVID-19
Sarah Friedrich, Tim Friede
The usual development cycles are too slow for the development of vaccines, diagnostics and treatments in pandemics such as the ongoing SARS-CoV-2 pandemic. Given the pressure in su…
Using clinical trial registries to inform Copas selection model for publication bias in meta-analysis
Ao Huang, Sho Komukai, Tim Friede +1
Prospective registration of study protocols in clinical trial registries is a useful way to minimize the risk of publication bias in meta-analysis, and several clinical trial regis…